
    
      The Primary Purpose of this study is to compare the effect of Yangxinshi on exercise
      tolerance of patients with percutaneous coronary intervention (PCI) for the first time with
      Trimetazidine, The target patients are the people who underwent PCI for the first time and
      can be carried on Cardiopulmonary exercise test. The treatment period was 24 weeks. The
      patients were randomly divided into two groups.ï¼š A: Yangxinshi pill 3 pills /tid and
      Trimetazidine mimic tablets 20mg/tid B: Trimetazidine mimic tablets 20mg/tid and Yangxinshi
      pill 3 pills /tid The patients were followed up for 0 weeks, 4 weeks, 12 weeks, 24 weeks and
      28 weeks after entering the group.
    
  